Showing results (411-420 of 709) with videos related to
Sort By:
Pageof 71
Journal of Receptor Research|January 1, 1993
Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptorJ L Wahlsten, J M Lindstrom, N Ostlie, et al.Journal of Receptor Research|January 1, 1992
Species- and subtype-specific recognition by antibody WF6 of a sequence segment forming an alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor alpha subunitK E McLane, M Fritzen, X Wu, et al.La Radiologia Medica|March 1, 1991
[Experience with more than 200 cases of breast biopsy after preoperative spatial localization without radiostereotaxic equipment]G Simonetti, G B Meloni, G Puoti, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 25, 1990
CD4+ T cell response to the human acetylcholine receptor alpha subunit in myasthenia gravis. A study with synthetic peptidesM P Protti, A A Manfredi, C Straub, et al.The Journal of Clinical Investigation|March 1, 1988
Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravisR Hohlfeld, K V Toyka, L L Miner, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 1, 1996
Dietary profiles and anti-oxidants in a rural population of central Italy with a low frequency of cancerM Caperle, G Maiani, E Azzini, et al.Biochemistry|July 13, 1993
Homologous kappa-neurotoxins exhibit residue-specific interactions with the alpha 3 subunit of the nicotinic acetylcholine receptor: a comparison of the structural requirements for kappa-bungarotoxin and kappa-flavitoxin bindingK E McLane, W R Weaver, S Lei, et al.European Journal of Immunology|December 1, 1995
Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjectsR Raju, D Navaneetham, D Okita, et al.Kidney International|June 1, 1993
ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IVM Yamaki, S McIntyre, J M Murphy, et al.The Journal of Biological Chemistry|August 11, 2000
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding siteM Grange, C Sette, M Cuomo, et al.Pageof 71